Patent details

Basic Information

Publication number:

EP1996232

PCT Application Number:

PCT/US/2007/004841

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077515922

PCT Publication Number:

WO/2007/103009

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES

French Title of Invention:

TRAITEMENT DU CANCER ASSOCIANT UN AGENT LYMPHODÉPLÉTEUR À DES CTL ET DES CYTOKINES

German Title of Invention:

KREBSBEHANDLUNG MIT KOMBINATION AUS LYMPHVERMINDERNDEM WIRKSTOFF UND CTLS UND ZYTOKINEN

SPC Number:

Dates

Filing date:

23/02/2007

Grant date:

06/04/2016

EP Publication Date:

06/04/2016

PCT Publication Date:

13/09/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/12/2008

EP B1 Publication Date:

06/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/02/2017

Expiration date:

23/02/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/02/2007

 

 

Name:

Janssen Pharmaceutica N.V.

Address:

Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Inventor

1

Name:

CAI Zeling

Address:

United States (US)

2

Name:

PETERSON Per, A.

Address:

United States (US)

3

Name:

RICHARDS Jon, M.

Address:

United States (US)

4

Name:

MORIARTY Ann

Address:

United States (US)

Priority

Priority Number:

778516 P

Priority Date:

01/03/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/21;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages